Quantum Biopharma Ltd. Files April 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Apr 24, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Quantum Biopharma (fka FSD Pharma) filed their April 6-K, confirming 20-F reporting.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on April 24, 2025, for the month of April 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, operates in the Pharmaceutical Preparations sector. This filing indicates they are submitting their report under Form 20-F.
Why It Matters
This filing provides an update on Quantum Biopharma's reporting status and confirms their adherence to SEC regulations for foreign private issuers. It signals ongoing operational and disclosure activities.
Risk Assessment
Risk Level: low — This is a routine reporting filing and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- April 2025 (date) — Reporting period
- 20250424 (date) — Filing date
- 001-39152 (other) — SEC file number
- Form 20-F (other) — Annual report form
- Form 6-K (other) — Report type
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of April 2025.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former company name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Which annual report form does Quantum Biopharma Ltd. indicate it files?
Quantum Biopharma Ltd. indicates it files annual reports under cover of Form 20-F.
Where is Quantum Biopharma Ltd.'s principal executive office located?
The principal executive office of Quantum Biopharma Ltd. is located at 55 University Ave., Suite 1003 Toronto, Ontario M5J2H7, Canada.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 24, 2025 regarding Quantum Biopharma Ltd. (QNTM).